|
2022-08-22 |
2022-08-19 |
B
Purchase
|
Bailey Gregory
Non-Executive Director
|
38,000
+1.5%
148.04
USD 5,625,676
|
38,000
+1.5%
|
148.04
|
USD 5,625,676
|
|
|
2022-05-12 |
2022-05-10 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
4,200
-50.8%
141.50
USD 594,300
|
4,200
-50.8%
|
141.50
|
USD 594,300
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
3,520
-36.9%
119.37
USD 420,180
|
3,520
-36.9%
|
119.37
|
USD 420,180
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
500
-5.0%
118.05
USD 59,024
|
500
-5.0%
|
118.05
|
USD 59,024
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
2,159
-17.7%
116.02
USD 250,485
|
2,159
-17.7%
|
116.02
|
USD 250,485
|
|
|
2022-01-24 |
2022-01-19 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
3,196
-20.8%
114.93
USD 367,314
|
3,196
-20.8%
|
114.93
|
USD 367,314
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
GREGORY JULIA P
Non-Executive Director
|
12,000
-100.0%
125.00
USD 1,500,000
|
12,000
-100.0%
|
125.00
|
USD 1,500,000
|
|
|
2021-12-22 |
2021-12-20 |
PS
Planned sale
|
Clark George C.
VP, Chief Accounting Officer
Officer
|
1,915
-18.9%
123.84
USD 237,154
|
1,915
-18.9%
|
123.84
|
USD 237,154
|
|
|
2021-12-16 |
2021-12-15 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
1,589
-17.5%
106.17
USD 168,701
|
1,589
-17.5%
|
106.17
|
USD 168,701
|
|
|
2021-12-16 |
2021-12-15 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
20,330
-69.2%
105.43
USD 2,143,426
|
20,330
-69.2%
|
105.43
|
USD 2,143,426
|
|
|
2021-12-16 |
2021-12-14 |
PS
Planned sale
|
Stock Elyse
Chief Medical Officer
Officer
|
6,939
-48.2%
105.02
USD 728,762
|
6,939
-48.2%
|
105.02
|
USD 728,762
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
1,382
-11.0%
103.85
USD 143,516
|
1,382
-11.0%
|
103.85
|
USD 143,516
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
23,487
-65.1%
102.70
USD 2,412,162
|
23,487
-65.1%
|
102.70
|
USD 2,412,162
|
|
|
2021-12-10 |
2021-12-10 |
PS
Planned sale
|
Engelhart James
Chief Financial Officer
Officer
|
10,131
-21.9%
102.01
USD 1,033,467
|
10,131
-21.9%
|
102.01
|
USD 1,033,467
|
|
|
2021-12-01 |
2021-11-29 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
11,499
-1.3%
113.25
USD 1,302,316
|
11,499
-1.3%
|
113.25
|
USD 1,302,316
|
|
|
2021-12-01 |
2021-11-29 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
13,026
-1.5%
112.40
USD 1,464,117
|
13,026
-1.5%
|
112.40
|
USD 1,464,117
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
7,073
-0.8%
117.87
USD 833,711
|
7,073
-0.8%
|
117.87
|
USD 833,711
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
18,230
-2.0%
116.69
USD 2,127,173
|
18,230
-2.0%
|
116.69
|
USD 2,127,173
|
|
|
2021-11-17 |
2021-11-16 |
S
Sale
|
Doogan Declan
Non-Executive Director
|
12,437
-1.3%
115.90
USD 1,441,501
|
12,437
-1.3%
|
115.90
|
USD 1,441,501
|
|
|
2021-11-10 |
2021-11-10 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
1,110
+0.0%
123.30
USD 136,862
|
1,110
+0.0%
|
123.30
|
USD 136,862
|
|
|
2021-11-10 |
2021-11-10 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
3,890
+0.2%
122.75
USD 477,480
|
3,890
+0.2%
|
122.75
|
USD 477,480
|
|
|
2021-03-17 |
2021-03-17 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
13,157
+0.5%
76.00
USD 999,932
|
13,157
+0.5%
|
76.00
|
USD 999,932
|
|
|
2021-03-03 |
2021-03-02 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
10,000
+0.4%
85.14
USD 851,370
|
10,000
+0.4%
|
85.14
|
USD 851,370
|
|
|
2020-11-23 |
2020-11-23 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
5,000
+0.2%
89.55
USD 447,737
|
5,000
+0.2%
|
89.55
|
USD 447,737
|
|
|
2020-11-04 |
2020-11-02 |
PS
Planned sale
|
JONES WILLIAM A JR
CCO-Migraine & Common Disease
Officer
|
1,300
-42.6%
77.70
USD 101,005
|
1,300
-42.6%
|
77.70
|
USD 101,005
|
|
|
2020-11-04 |
2020-11-02 |
PS
Planned sale
|
JONES WILLIAM A JR
CCO-Migraine & Common Disease
Officer
|
4,010
-56.8%
77.01
USD 308,799
|
4,010
-56.8%
|
77.01
|
USD 308,799
|
|
|
2020-11-04 |
2020-11-02 |
PS
Planned sale
|
JONES WILLIAM A JR
CCO-Migraine & Common Disease
Officer
|
24,690
-77.8%
76.02
USD 1,876,872
|
24,690
-77.8%
|
76.02
|
USD 1,876,872
|
|
|
2020-10-23 |
2020-10-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
212
-0.0%
79.94
USD 16,948
|
212
-0.0%
|
79.94
|
USD 16,948
|
|
|
2020-10-23 |
2020-10-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
10,191
-0.4%
78.89
USD 803,918
|
10,191
-0.4%
|
78.89
|
USD 803,918
|
|
|
2020-10-23 |
2020-10-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
3,100
-0.1%
79.88
USD 247,632
|
3,100
-0.1%
|
79.88
|
USD 247,632
|
|
|
2020-10-23 |
2020-10-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
21,466
-0.8%
79.41
USD 1,704,720
|
21,466
-0.8%
|
79.41
|
USD 1,704,720
|
|
|
2020-10-21 |
2020-10-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
4,554
-0.2%
78.98
USD 359,655
|
4,554
-0.2%
|
78.98
|
USD 359,655
|
|
|
2020-10-21 |
2020-10-16 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
3,748
-0.1%
78.88
USD 295,638
|
3,748
-0.1%
|
78.88
|
USD 295,638
|
|
|
2020-10-14 |
2020-10-12 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
6,729
-0.3%
78.87
USD 530,740
|
6,729
-0.3%
|
78.87
|
USD 530,740
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
2,458
-40.3%
77.42
USD 190,300
|
2,458
-40.3%
|
77.42
|
USD 190,300
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
15,781
-72.1%
76.42
USD 1,205,938
|
15,781
-72.1%
|
76.42
|
USD 1,205,938
|
|
|
2020-10-09 |
2020-10-08 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
5,261
-19.4%
75.62
USD 397,844
|
5,261
-19.4%
|
75.62
|
USD 397,844
|
|
|
2020-09-22 |
2020-09-21 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
3,322
+0.1%
59.25
USD 196,829
|
3,322
+0.1%
|
59.25
|
USD 196,829
|
|
|
2020-09-14 |
2020-09-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
6,678
+0.3%
59.00
USD 393,984
|
6,678
+0.3%
|
59.00
|
USD 393,984
|
|
|
2020-08-12 |
2020-08-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
15,129
+0.6%
61.87
USD 936,093
|
15,129
+0.6%
|
61.87
|
USD 936,093
|
|
|
2020-08-12 |
2020-08-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
7,271
+0.3%
61.28
USD 445,568
|
7,271
+0.3%
|
61.28
|
USD 445,568
|
|
|
2020-08-12 |
2020-08-11 |
B
Purchase
|
CHILDS JOHN W
Non-Executive Director
|
2,600
+0.1%
60.32
USD 156,824
|
2,600
+0.1%
|
60.32
|
USD 156,824
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
5,991
-0.2%
75.93
USD 454,888
|
5,991
-0.2%
|
75.93
|
USD 454,888
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
2,778
-89.1%
75.29
USD 209,145
|
2,778
-89.1%
|
75.29
|
USD 209,145
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
55,626
-94.7%
75.25
USD 4,185,745
|
55,626
-94.7%
|
75.25
|
USD 4,185,745
|
|
|
2020-07-10 |
2020-07-08 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
44,009
-1.7%
75.12
USD 3,305,877
|
44,009
-1.7%
|
75.12
|
USD 3,305,877
|
|
|
2020-06-25 |
2020-06-24 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
2,395
-0.1%
70.24
USD 168,225
|
2,395
-0.1%
|
70.24
|
USD 168,225
|
|
|
2020-06-25 |
2020-06-24 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
1,600
-0.1%
69.29
USD 110,865
|
1,600
-0.1%
|
69.29
|
USD 110,865
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
835
-0.0%
75.18
USD 62,779
|
835
-0.0%
|
75.18
|
USD 62,779
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
63,257
-2.3%
74.60
USD 4,719,257
|
63,257
-2.3%
|
74.60
|
USD 4,719,257
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
24,084
-0.9%
73.72
USD 1,775,369
|
24,084
-0.9%
|
73.72
|
USD 1,775,369
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
4,296
-92.6%
75.05
USD 322,431
|
4,296
-92.6%
|
75.05
|
USD 322,431
|
|
|
2020-06-25 |
2020-06-23 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
13,467
-0.5%
72.70
USD 979,027
|
13,467
-0.5%
|
72.70
|
USD 979,027
|
|
|
2020-06-22 |
2020-06-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
49,132
-1.8%
73.64
USD 3,618,012
|
49,132
-1.8%
|
73.64
|
USD 3,618,012
|
|
|
2020-06-22 |
2020-06-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
20,659
-0.7%
72.91
USD 1,506,202
|
20,659
-0.7%
|
72.91
|
USD 1,506,202
|
|
|
2020-06-22 |
2020-06-22 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
10,540
-0.4%
72.01
USD 758,961
|
10,540
-0.4%
|
72.01
|
USD 758,961
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
986
-74.3%
75.07
USD 74,016
|
986
-74.3%
|
75.07
|
USD 74,016
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
428
-0.0%
75.22
USD 32,193
|
428
-0.0%
|
75.22
|
USD 32,193
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
22,584
-0.8%
73.78
USD 1,666,268
|
22,584
-0.8%
|
73.78
|
USD 1,666,268
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
12,157
-0.4%
72.93
USD 886,619
|
12,157
-0.4%
|
72.93
|
USD 886,619
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
21,798
-0.8%
71.98
USD 1,568,935
|
21,798
-0.8%
|
71.98
|
USD 1,568,935
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
58,238
-2.0%
70.91
USD 4,129,855
|
58,238
-2.0%
|
70.91
|
USD 4,129,855
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
26,814
-0.9%
70.10
USD 1,879,793
|
26,814
-0.9%
|
70.10
|
USD 1,879,793
|
|
|
2020-06-22 |
2020-06-19 |
PS
Planned sale
|
Bailey Gregory
Non-Executive Director
|
22,012
-0.7%
69.01
USD 1,519,094
|
22,012
-0.7%
|
69.01
|
USD 1,519,094
|
|
|
2020-06-22 |
2020-06-18 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
1,400
-80.4%
76.05
USD 106,467
|
1,400
-80.4%
|
76.05
|
USD 106,467
|
|
|
2020-06-22 |
2020-06-18 |
PS
Planned sale
|
Berman Robert
Special Projects & Med Ovrsght
Officer
|
59,914
-97.2%
75.25
USD 4,508,822
|
59,914
-97.2%
|
75.25
|
USD 4,508,822
|
|
|
2020-06-18 |
2020-06-17 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
400
-9.9%
70.20
USD 28,081
|
400
-9.9%
|
70.20
|
USD 28,081
|
|
|
2020-06-17 |
2020-06-17 |
PS
Planned sale
|
Gentile Kimberly
SVP, Clinical Operations
Officer
|
24,000
-86.8%
70.20
USD 1,684,870
|
24,000
-86.8%
|
70.20
|
USD 1,684,870
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
300
-0.0%
69.42
USD 20,825
|
300
-0.0%
|
69.42
|
USD 20,825
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
25,208
-3.9%
68.73
USD 1,732,458
|
25,208
-3.9%
|
68.73
|
USD 1,732,458
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
31,920
-4.7%
67.90
USD 2,167,515
|
31,920
-4.7%
|
67.90
|
USD 2,167,515
|
|
|
2020-06-17 |
2020-06-16 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
2,572
-0.4%
66.94
USD 172,162
|
2,572
-0.4%
|
66.94
|
USD 172,162
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
15,797
-2.3%
68.10
USD 1,075,801
|
15,797
-2.3%
|
68.10
|
USD 1,075,801
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
18,703
-2.6%
67.51
USD 1,262,557
|
18,703
-2.6%
|
67.51
|
USD 1,262,557
|
|
|
2020-06-17 |
2020-06-15 |
PS
Planned sale
|
Doogan Declan
Non-Executive Director
|
34,336
-4.5%
66.05
USD 2,267,872
|
34,336
-4.5%
|
66.05
|
USD 2,267,872
|
|
